Heart attack diagnosis could become dramatically faster and more accessible with a breakthrough that combines artificial intelligence with miniaturized testing technology. Current emergency cardiac assessments often require hours in hospital laboratories, creating dangerous delays when every minute counts for heart muscle survival.
Researchers developed a paper-based testing cartridge that simultaneously measures three critical cardiac biomarkers—troponin I, creatine kinase-MB, and NT-proBNP—from just 50 microliters of blood serum within 23 minutes. The device integrates two complementary detection methods: colorimetric and chemiluminescent sensing, enabling measurement across six orders of magnitude concentration ranges. This dual approach captures both subtle early indicators and high-level markers present during severe cardiac events. Deep learning algorithms analyze the optical signals, achieving greater than 96% correlation with gold-standard laboratory methods when tested on 92 patient samples.
This advancement addresses a fundamental limitation in emergency cardiology: the trade-off between speed and comprehensiveness. Traditional point-of-care tests typically measure single biomarkers with limited sensitivity ranges, potentially missing nuanced cardiac conditions. The new system's ability to simultaneously quantify multiple markers with sub-picogram sensitivity for troponin represents a significant leap toward comprehensive rapid diagnosis. For healthcare systems, this could enable accurate cardiac risk stratification in ambulances, rural clinics, or emergency departments lacking full laboratory capabilities. However, real-world validation across diverse patient populations and clinical settings remains essential before widespread implementation.